Science Explorer Interactive view Map
Company · Cambridge · United States

Foghorn Therapeutics (United States)

foghorntx.comROR OpenAlex
Research works
43
▲ 480% vs 2013–17
Citations
722
16.6 per fractional work
Top-10% rate
12.3%
record average 16.5%
Open access
42%
world 28%

Not ranked overall: Foghorn Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 11.72× its world share, 15 worksBiochemistry, Geneti…Immunology and Microbiology: 6.15× its world share, 1 worksImmunology and Micro…Neuroscience: 0.59× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.05× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.37× its world share, 0 worksChemistryComputer Science: 0.09× its world share, 0 worksComputer ScienceEngineering: 0.10× its world share, 0 worksEngineeringEnvironmental Science: 0.22× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.41× its world share, 0 worksMaterials ScienceHealth Professions: 0.05× its world share, 0 worksHealth ProfessionsMedicine: 1.13× its world share, 5 worksMedicineNursing: 0.36× its world share, 0 worksNursing1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 11.7×. Every wedge is a field page.

Which keywords describe research at Foghorn Therapeutics (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Transcriptional Regulation, Epigenetics, BET Bromodomains, PROTACs, Chromatin Remodeling, SWI/SNF Complexes and Cancer Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 21 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Cancer5▲ 16×4 topics
  2. Epigenetics5▲ 469×2 topics
  3. Transcriptional Regulation5▲ 123×5 topics
  4. BET Bromodomains4▲ 615×1 topic
  5. PROTACs4▲ 615×1 topic
  6. Chromatin Remodeling4▲ 1656×1 topic
  7. SWI/SNF Complexes4▲ 1656×1 topic
  8. Cancer Therapy2▲ 18×5 topics
  9. Prognostic Factors2▲ 17×4 topics
  10. Tumor Microenvironment1▲ 14×2 topics
  11. Inflammation1▲ 2.8×6 topics
  12. AML1▲ 104×1 topic
  13. Acute Myeloid Leukemia1▲ 104×1 topic
  14. Epigenetic Regulation1▲ 22×2 topics
  15. Gene Regulation1▲ 54×2 topics
  16. HDAC Inhibitors1▲ 210×1 topic
  17. Histone Deacetylases1▲ 210×1 topic
  18. Immunity1▲ 12×2 topics
  19. HIF-11▲ 72×1 topic
  20. Nanoparticles1▲ 3.4×4 topics
  21. Warburg Effect1▲ 72×1 topic

Which research topics does Foghorn Therapeutics (United States) publish most on?

By volume in 2022–2025: Protein Degradation and Inhibitors, Chromatin Remodeling and Cancer, Acute Myeloid Leukemia Research and Histone Deacetylase Inhibitors Research.

Protein Degradation and …4Protein Degradation and Inhibitors: 4 fractional worksChromatin Remodeling and…4Chromatin Remodeling and Cancer: 4 fractional worksAcute Myeloid Leukemia Research: 1 fractional worksHistone Deacetylase Inhibitors Research: 1 fractional worksCancer, Hypoxia, and Metabolism: 1 fractional worksMechanisms of cancer metastasis: 1 fractional worksImmune cells in cancer: 1 fractional worksGenomics and Chromatin Dynamics: 1 fractional worksCancer Mechanisms and Therapy: 1 fractional worksUbiquitin and proteasome pathways: 1 fractional works
Molecular BiologyHematologyCancer ResearchImmunology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Protein Degradation and Inhibitors Molecular Biology 4 works
  2. 2 Chromatin Remodeling and Cancer Molecular Biology 4 works
  3. 3 Acute Myeloid Leukemia Research Hematology 1 works
  4. 4 Histone Deacetylase Inhibitors Research Molecular Biology 1 works
  5. 5 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
  6. 6 Mechanisms of cancer metastasis Molecular Biology 1 works
  7. 7 Immune cells in cancer Immunology 1 works
  8. 8 Genomics and Chromatin Dynamics Molecular Biology 1 works
  9. 9 Cancer Mechanisms and Therapy Pathology and Forensic Medicine 1 works
  10. 10 Ubiquitin and proteasome pathways Molecular Biology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.4%not open57.6%

World: 28% of research is openly available.

with international co-authors14.8%domestic only85.2%

World: 19% is written across borders.

How has Foghorn Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 480% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.